Total Portfolio Value
Annualized Revenues Of Top 40% Companies
Total Number Of Founders
Total Number Of Jobs Created
Internal Rate Of Return
Aspect has developed a disruptive 3D bioprinting platform based on its proprietary Lab-on-a-Printer™ technology, capable of creating living Human Tissues on Demand™ for broad applications in the life sciences. Aspect’s technology is enabling advances in fundamental biology, drug development through novel pre-clinical models, and regenerative medicine where in the future, lifesaving transplant organs will be created, not harvested.
Avelabs is a future focused supplier of embedded solutions and services for the automotive industry, with offices in Munich, Stuttgart and Cairo, Avelabs caters to clients across the globe. With major contributions in vast variety of ECUs for many vehicles manufacturers, Avelabs enables its clients to focus on innovation by offering solutions and services for AUTOSAR, embedded linux, MBD, functional safety and ADAS.
Foundation of Avelabs LLC in Cairo
AUTOSAR development member
Avelabs SL Germany establishment in Munich
First Release of Gaspra ARTiA tool
First Deployment of Aveloader
Expanding Avelabs R&D facility in Cairo to Maadi TechPark
Avelabs joins COMASSO association
New office in Stuttgart for Avelabs SL
Careem is the MENA region’s leading ride-hailing service, providing customers with reliable, safe, convenient, and affordable travel and disrupting the way people move every day.
A physician-only community for expert answers to real world clinical questions in oncology. We help physicians get answers to questions where there is no clear answer in guidelines or published research and expert opinion is necessary. All answers are indexed and searchable so that every physician can quickly access expert knowledge to provide their patients with high quality care.
Nas Trends aims to become the world’s strongest fashion brand among the youth – or old people who still feel the power of youth – by 2020. In the near future, NAS will continue to break down the existing understanding fashion, and convert it to community driven one, that the youth themselves drive toward a better one.
Y Combinator-backed healthcare startup building the first clinically-proven digital treatment for digestive health and IBS. We believe your healthcare should be personalized and data-driven -- cutting-edge science, top physicians, and expert coaching, all wrapped up in a treatment plan built just for your body. A Groundbreaking Digital Solution for Digestive Health.
Mavericks is the first school in Egypt to adopt Blended Learning. We leverage innovative teaching methods and technology to build problem solvers who are capable of realizing their own potential and solving the world's toughest problems.
Xtrava team has been developing breakthrough contact-less bio-sensing technology with significant potential in numerous health and wellness applications and has released their first product: Butterfly - The Child Wellness Monitor. Butterfly is the world’s only wearable child wellness monitor that provides actionable insights to parents by automatically tracking their child’s vitals, sleep, feeding, diaper and activities.
Sourceress is an AI recruiter that is reinventing how people find jobs. With tailor-made machine learning models, we rigorously define what a company is looking for in a role, identify great candidates, and engage candidates with highly personalized introductions. Our process creates a stream of interested candidates that hiring managers are excited about more than 85% of the time.
Working on standardizing the hardware and software interface between the body and any bionic device to enable high functionality bionics for treating health conditions to be easily and cheaply developed & delivered to patients.
Cambridge Cancer Genomics is an award-winning health startup with international recognition from prestigious programs including Y combinator. We are transforming the way cancer patients are treated, through next generation liquid biopsies and smart genomics. Currently, cancer patients may wait months to know whether their chemotherapy is working. In the interim, these patients suffer the side effects. Using simple blood samples, CCG shortens the time required to know whether treatment is working, giving the clinician more time to alter ineffective treatments and reduce unnecessary side effects.